Organic Process Research & Development 2010, 14, 1485–1489
Risk Assessment and Safety Evaluation Study for Ozonolysis of ꢀ-Pinene: Raw
Material of a Novel Prostaglandin D2 Receptor Antagonist S-5751
Takemasa Hida,*,† Junko Kikuchi,‡ Makoto Kakinuma,§ and Hideo Nogusa§
Shanghai Office, Shionogi & Co., Ltd., 306A, 3F, Building A, Far East International Plaza, No. 319, Xianxia Road,
Shanghai 200051, China, DiscoVery Research Laboratories, Shionogi & Co., Ltd., 12-4, Sagisu 5-chome, Fukushima-ku,
Osaka 553-0002, Japan, and CMC DeVelopment Laboratories, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-chome, Amagasaki,
Hyogo 660-0813, Japan
Scheme 1. New synthetic route to S-5751 1 from ꢀ-pinene 2
Abstract:
Safety evaluation for ozonolysis of ꢀ-pinene was conducted using
DSC, ARC, and RC1e. ARC measurement showed that the
concentration of the ozonized mixture affects its thermal stability.
The sample at a high concentration of 1.83 mol/L was very
unstable even at room temperature and decomposed rapidly.
ADT24 of the diluted sample of 0.73 mol/L was 28.2 °C.
Although reductive decomposition of the ozonized mixture
at extremely low temperature is very dangerous because of
accumulation of the heat of reaction, its process temperature
was validated to not exceed the ADT24. As a result, pilot
manufacturing on a 300-L reactor scale could be achieved.
have been reported for obtaining its key intermediate.8-10
new synthetic route from 3 to (+)-2-((1R,2R,3R,5S)-2-amino-
6,6-dimethylbicyclo[3.1.1]hept-3-yl)-ethanol (4), which is one
of the key intermediates of S-5751, was reported by the
Shionogi group.10 To obtain 3, ozonolysis of ꢀ-pinene 2 is
necessary. Although a procedure for obtaining 3 from 2 using
ozonolysis has been reported by Grimshaw et al.,11 a detailed
safety evaluation study is necessary for scale-up manufacturing
of 3. Here we describe a risk assessment and detailed safety
evaluation study of ozonolysis and present a case of practical
application for scale-up ozonolysis.
A
Introduction
Since Scho¨nbein first studied ozonolysis in 1855,1 this
reaction has been applied to many types of industrial produc-
tion,2 for example, for the preparation of antibiotics such as
ceftibuten and cefaclor.3,4 Ozonolysis is a useful reaction for
obtaining carbonyl compounds directly from olefins, and ozone
is a very “green” oxidant because it only produces oxygen as
a coproduct after the reaction. However, ozonolysis is known
to be a very dangerous reaction which may cause explosions.
Recently, microreactor systems have been used for kilogram-
scale synthesis,5 but detailed safety evaluation study and risk
assessment of ozonolysis are needed for practical industrial
manufacturing.
Results & Discussion
Identification of Products from Ozonolysis and Their
Evaluation Using CHETAH. Reaction products were deter-
mined by NMR of the reaction mixture. The reaction mecha-
nism by Criegee12 is outlined as follows (Scheme 2). In the
first step, ozone and 2 made the 1,2,3-trioxolane structure
(primary ozonide 5). In the second step, 5 underwent heterolysis
to give a zwitterion (6 or 7) and a carbonyl compound (3 or
formaldehyde 8). In the final step, the zwitterion combined with
the carbonyl compound to give normal ozonide 9. However
this ozonolysis was carried out in methanol. In a protonic
solvent, here methanol, 7 can be easily diverted to 10 instead
(+)-Nopinone 3 is a raw material of the prostaglandin D2
(PGD2) receptor antagonist S-5751 1, which was discovered at
Shionogi Research Laboratories.6,7 Several synthetic methods
* To whom correspondence should be addressed. Fax: 86-21-6235-1311.
Telephone: 86-21-6235-1311. E-mail: takemasa.hida@shionogi.co.jp.
† Shanghai Office, Shionogi & Co., Ltd.
‡ Discovery Research Laboratories, Shionogi & Co., Ltd.
§ CMC Development Laboratories, Shionogi & Co., Ltd.
(1) Scho¨nbein, C. F. J. Pract. Chem. 1855, 66, 282.
(2) Van Ornum, S. G.; Champeau, R. M.; Pariza, R. Chem. ReV. 2006,
106, 2990.
(8) (a) Campos, K. R.; Lee, S.; Journet, M.; Kowal, J. J.; Cai, D.; Larsen,
R. D.; Reider, P. J. Tetrahedron Lett. 2002, 43, 6957. (b) Campos,
K. R.; Journet, M.; Lee, S.; Cai, D.; Kowal, J. J.; Lee, S.; Larsen,
R. D.; Reider, P. J. J. Org. Chem. 2003, 68, 2338.
(3) Yoshioka, M. Pure Appl. Chem. 1987, 59, 1041.
(4) Bernasconi, E.; Lee, J.; Sogli, L.; Walker, D. Org. Process Res. DeV.
2002, 6, 169.
(5) Hu¨bner, S.; Bentrup, U.; Budde, U.; Lovis, K.; Dietrich, T.; Freitag,
A.; Ku¨pper, L.; Ja¨hnisch, K. Org. Process Res. DeV. 2009, 13, 952.
(6) Arimura, A.; Yasui, K.; Kishino, J.; Asanuma, F.; Hasegawa, H.;
Kakudo, S.; Ohtani, M.; Arita, H. J. Pharmacol. Exp. Ther. 2001,
298, 411.
(9) Jennequin, T.; Labat, S.; Toupet, L.; Caille, J. C.; Mauduit, M. Synlett
2008, 11, 1669.
(10) Hida, T.; Mitsumori, S.; Honma, T.; Hiramatsu, Y.; Hashizume, H.;
Okada, T.; Kakinuma, M.; Kawata, K.; Oda, K.; Hasegawa, A.; Masui,
T.; Nogusa, H. Org. Process Res. DeV. 2009, 13, 1413.
(11) Grimshaw, J.; Grimshaw, J. T.; Junejia, H. R. J. Chem. Soc. Perkin 1
1972, 50.
(7) Mitsumori, S.; Tsuri, T.; Honma, T.; Hiramatsu, Y.; Okada, T.;
Hashizume, H.; Kida, S.; Inagaki, M.; Arimura, A.; Yasui, K.;
Asanuma, F.; Kishino, J.; Ohtani, M. J. Med. Chem. 2003, 46, 2446.
(12) Criegee, R.; Scro¨der, G. Chem. Ber. 1960, 93, 689.
10.1021/op100065d 2010 American Chemical Society
Published on Web 06/15/2010
Vol. 14, No. 6, 2010 / Organic Process Research & Development
•
1485